Biohaven Pharmaceutical Holding (BHVN) PT Raised to $80 at Cowen After Speaking with Migraine Consultants
Tweet Send to a Friend
Cowen analyst Ken Cacciatore raised the price target on Biohaven Pharmaceutical Holding (NYSE: BHVN) to $80.00 (from $60.00) after receiving ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
